ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 259 filers reported holding ACCELERON PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $30,083,000 | +10.7% | 174,802 | -19.3% | 0.02% | +11.1% |
Q2 2021 | $27,168,000 | +21.5% | 216,489 | +31.3% | 0.02% | +12.5% |
Q1 2021 | $22,361,000 | +15.2% | 164,896 | +8.7% | 0.02% | +14.3% |
Q4 2020 | $19,409,000 | +6.8% | 151,706 | -6.1% | 0.01% | -6.7% |
Q3 2020 | $18,171,000 | +17.6% | 161,478 | -0.5% | 0.02% | +7.1% |
Q2 2020 | $15,453,000 | +53.7% | 162,211 | +45.0% | 0.01% | +27.3% |
Q1 2020 | $10,056,000 | +43.1% | 111,891 | -15.6% | 0.01% | +83.3% |
Q4 2019 | $7,028,000 | +26.1% | 132,547 | -6.1% | 0.01% | +20.0% |
Q3 2019 | $5,575,000 | -7.2% | 141,090 | -3.5% | 0.01% | 0.0% |
Q2 2019 | $6,007,000 | -11.3% | 146,236 | +0.5% | 0.01% | -16.7% |
Q1 2019 | $6,773,000 | +10.1% | 145,455 | +3.0% | 0.01% | -14.3% |
Q4 2018 | $6,149,000 | -28.9% | 141,199 | -6.6% | 0.01% | -12.5% |
Q3 2018 | $8,649,000 | +8.6% | 151,144 | -7.9% | 0.01% | +14.3% |
Q2 2018 | $7,961,000 | +50.3% | 164,066 | +21.1% | 0.01% | +40.0% |
Q1 2018 | $5,298,000 | -9.2% | 135,491 | -1.5% | 0.01% | 0.0% |
Q4 2017 | $5,836,000 | +48.9% | 137,529 | +31.0% | 0.01% | +25.0% |
Q3 2017 | $3,919,000 | +23.7% | 105,022 | +0.8% | 0.00% | +33.3% |
Q2 2017 | $3,168,000 | +16.0% | 104,234 | +1.0% | 0.00% | 0.0% |
Q1 2017 | $2,732,000 | +1.3% | 103,195 | -2.4% | 0.00% | 0.0% |
Q4 2016 | $2,698,000 | -27.7% | 105,742 | +2.6% | 0.00% | -40.0% |
Q3 2016 | $3,731,000 | +13.1% | 103,090 | +6.2% | 0.01% | 0.0% |
Q2 2016 | $3,299,000 | +25.5% | 97,100 | -2.5% | 0.01% | +25.0% |
Q1 2016 | $2,628,000 | -45.9% | 99,600 | 0.0% | 0.00% | -42.9% |
Q4 2015 | $4,856,000 | +105.7% | 99,600 | +5.1% | 0.01% | +75.0% |
Q3 2015 | $2,361,000 | -21.0% | 94,800 | +0.4% | 0.00% | 0.0% |
Q2 2015 | $2,987,000 | +24.6% | 94,400 | +49.8% | 0.00% | 0.0% |
Q1 2015 | $2,398,000 | +50.8% | 63,000 | +54.4% | 0.00% | +100.0% |
Q4 2014 | $1,590,000 | +32.1% | 40,800 | +2.5% | 0.00% | 0.0% |
Q3 2014 | $1,204,000 | -10.9% | 39,800 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $1,352,000 | -1.5% | 39,800 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $1,373,000 | -14.2% | 39,800 | -1.5% | 0.00% | -33.3% |
Q4 2013 | $1,600,000 | – | 40,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |